EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines

Epidermal growth factor receptor (EGFR) is involved in multiple aspects of cancer cell biology. EGFR has already been identified as an important target for cancer therapy, with various kinds of EGFR inhibitors currently used in treatment of several human cancers. Recently, EGFR and its downstream si...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiraishi, Yukihiro, Wada, Takeshi, Nakatani, Ken, Tojyo, Itaru, Matsumoto, Takashi, Kiga, Norifumi, Negoro, Kenji, Fujita, Shigeyuki
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2008
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413131/
https://www.ncbi.nlm.nih.gov/pubmed/18347929
http://dx.doi.org/10.1007/s12253-008-9020-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413131/
https://www.ncbi.nlm.nih.gov/pubmed/18347929
http://dx.doi.org/10.1007/s12253-008-9020-5

Ejemplares similares